dr. arend on unmet needs in platinum-resistant ovarian cancer
Published 4 years ago • 329 plays • Length 1:09Download video MP4
Download video MP3
Similar videos
-
1:41
unmet clinical needs for platinum-resistant ovarian cancer patients
-
1:14
dr. arend on niraparib with bevacizumab in ovarian cancer
-
3:15
unmet needs in ovarian cancer
-
14:46
managing platinum-resistant ovarian cancer
-
1:18
dr. arend on the rationale of novel combinations in gynecologic cancer
-
1:35
dr. arend on novel combination strategies in gynecologic cancer
-
2:19
dr. arend on fda approval of frontline bevacizumab in ovarian cancer
-
26:58
ask the experts: adcs in ovarian cancer
-
2:19
dr. moore on anticipated impact of the mirasol trial in platinum-resistant ovarian cancer
-
10:22
aravive, inc. - platinum resistant ovarian cancer
-
6:54
adc in platinum-resistant ovarian cancer
-
1:19
relacorilant nab-paclitaxel in recurrent, platinum-resistant ovarian cancer
-
6:57
bevacizumab in platinum-resistant ovarian cancer
-
1:12
dr. arend discusses targets in endometrial cancer
-
1:22
dr. naumann on data with stro-002 in platinum-resistant/refractory ovarian cancer
-
1:41
dr. konner on preferred platinum doublets in recurrent ovarian cancer
-
0:40
dr. willmott on fda approval of maintenance olaparib in ovarian cancer
-
0:50
dr. arend on the portec-3 trial for endometrial cancer
-
2:20
dr. matulonis discusses niraparib/pembrolizumab combo in platinum-resistant ovarian cancer